103 related articles for article (PubMed ID: 6628467)
21. Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
Scher HI; Liebertz C; Kelly WK; Mazumdar M; Brett C; Schwartz L; Kolvenbag G; Shapiro L; Schwartz M
J Clin Oncol; 1997 Aug; 15(8):2928-38. PubMed ID: 9256137
[TBL] [Abstract][Full Text] [Related]
22. [Clinical course of bone metastases by prostatic cancer studies with conventional X-ray].
Higa T; Akimoto S; Isaka S; Shimazaki J; Goto S
Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):734-43. PubMed ID: 1875568
[TBL] [Abstract][Full Text] [Related]
23. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
Shreve PD; Grossman HB; Gross MD; Wahl RL
Radiology; 1996 Jun; 199(3):751-6. PubMed ID: 8638000
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate.
Berry WR; Laszlo J; Cox E; Walker A; Paulson D
Cancer; 1979 Aug; 44(2):763-75. PubMed ID: 476583
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between extent of bone metastases and effect of endocrine therapy evaluated with bone scintigraphy in stage D2 prostatic cancer].
Tanaka M; Murakami S; Akimoto S; Masai M; Shimazaki J
Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1036-42. PubMed ID: 1507721
[TBL] [Abstract][Full Text] [Related]
26. Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study.
Nakajima K; Kaneko G; Takahashi S; Matsuyama H; Shiina H; Ichikawa T; Horikoshi H; Hashine K; Sugiyama Y; Miyao T; Kamiyama M; Harada K; Ito A; Mizokami A;
Int J Urol; 2018 May; 25(5):492-499. PubMed ID: 29633398
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of skeletal metastases in prostatic cancer using gamma camera (author's transl)].
Langhammer H; Sintermann R; Kempken K; Hör G; Pabst HW; Fendl M
Med Klin; 1977 May; 72(21):942-51. PubMed ID: 875870
[TBL] [Abstract][Full Text] [Related]
28. Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
Amico S; Liehn JC; Desoize B; Larbre H; Deltour G; Valeyre J
Clin Nucl Med; 1991 Sep; 16(9):643-8. PubMed ID: 1718651
[TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in the diagnosis of bone metastasis in prostate cancer.
Lorente JA; Morote J; Raventos C; Encabo G; Valenzuela H
J Urol; 1996 Apr; 155(4):1348-51. PubMed ID: 8632571
[TBL] [Abstract][Full Text] [Related]
30. Distribution pattern of metastatic bone disease. A need for total body skeletal image.
Krishnamurthy GT; Tubis M; Hiss J; Blahd WH
JAMA; 1977 Jun; 237(23):2504-6. PubMed ID: 576963
[TBL] [Abstract][Full Text] [Related]
31. Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer.
Morris MJ; Akhurst T; Osman I; Nunez R; Macapinlac H; Siedlecki K; Verbel D; Schwartz L; Larson SM; Scher HI
Urology; 2002 Jun; 59(6):913-8. PubMed ID: 12031380
[TBL] [Abstract][Full Text] [Related]
32. Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate.
Schaffer DL; Pendergrass HP
Radiology; 1976 Nov; 121(2):431-4. PubMed ID: 981622
[TBL] [Abstract][Full Text] [Related]
33. Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.
Bombardieri E; Setti L; Kirienko M; Antunovic L; Guglielmo P; Ciocia G
Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):381-99. PubMed ID: 26337240
[TBL] [Abstract][Full Text] [Related]
34. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan.
Soloway MS; Hardeman SW; Hickey D; Raymond J; Todd B; Soloway S; Moinuddin M
Cancer; 1988 Jan; 61(1):195-202. PubMed ID: 3334948
[TBL] [Abstract][Full Text] [Related]
35. [The usefulness of early whole body bone scintigraphy in the detection of bone metastasis from prostatic cancer].
Otsuka N; Fukunaga M; Furukawa Y; Tanaka H
Kaku Igaku; 1994 Jun; 31(6):541-50. PubMed ID: 7520953
[TBL] [Abstract][Full Text] [Related]
36. Bone Scan Index Is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: A Prospective Study.
Zacho HD; Gade M; Mortensen JC; Bertelsen H; Boldsen SK; Barsi T; Petersen LJ
Urology; 2017 Oct; 108():135-141. PubMed ID: 28760556
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow aspiration biopsy and bone scanning in the staging of prostatic cancer.
Varenhorst E; Alund G; Lindström E; Månson JC
Br J Urol; 1983 Oct; 55(5):534-7. PubMed ID: 6626900
[TBL] [Abstract][Full Text] [Related]
38. Lung metastases in prostatic carcinoma. Clinical significance.
Varkarakis MJ; Winterberger AR; Gaeta J; Moore RH; Murphy GP
Urology; 1974 Apr; 3(4):447-52. PubMed ID: 4856662
[No Abstract] [Full Text] [Related]
39. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M
Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459
[TBL] [Abstract][Full Text] [Related]
40. The treatment of metastatic prostatic cancer with the slow release LH-RH analogue Zoladex ICI 118630.
Beacock CJ; Buck AC; Zwinck R; Peeling WB; Rees RW; Turkes A; Walker K; Griffiths K
Br J Urol; 1987 May; 59(5):436-42. PubMed ID: 2954605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
